369 related articles for article (PubMed ID: 26995779)
1. Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease.
Adam B; Koldehoff M; Ditschkowski M; Gromke T; Hlinka M; Trenschel R; Kordeals L; Steckel NK; Beelen DW; Liebregts T
Dig Dis Sci; 2016 Jul; 61(7):2019-26. PubMed ID: 26995779
[TBL] [Abstract][Full Text] [Related]
2. Fecal calprotectin as a biomarker of intestinal graft versus host disease after allogeneic hematopoietic stem cell transplantation.
Lorenz F; Marklund S; Werner M; Palmqvist R; Wahlin BE; Wahlin A
Sci Rep; 2015 Jan; 5():7920. PubMed ID: 25605402
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease.
Broglie L; Rademaker A; Galvin J; Ray A; Tse WT; Duerst R; Schneiderman J; Kletzel M; Chaudhury S
Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):169-174. PubMed ID: 29397331
[TBL] [Abstract][Full Text] [Related]
4. Cecum ulcer is a reliable endoscopic finding in cytomegalovirus colitis concomitant with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Matsuda K; Ono S; Ishikawa M; Miyamoto S; Abiko S; Tsuda M; Yamamoto K; Kudo T; Shimizu Y; Hayase E; Hashimoto D; Teshima T; Matsuno Y; Sakamoto N
Ann Hematol; 2018 May; 97(5):877-883. PubMed ID: 29340759
[TBL] [Abstract][Full Text] [Related]
5. Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease.
Rodriguez-Otero P; Porcher R; Peffault de Latour R; Contreras M; Bouhnik Y; Xhaard A; Andreoli A; Ribaud P; Kapel N; Janin A; Socié G; Robin M
Blood; 2012 Jun; 119(24):5909-17. PubMed ID: 22555971
[TBL] [Abstract][Full Text] [Related]
6. Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation.
Metafuni E; Giammarco S; De Ritis DG; Rossi M; De Michele T; Zuppi C; Bacigalupo AP; Sica S; Chiusolo P
Ann Hematol; 2017 Jun; 96(6):929-933. PubMed ID: 28293713
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological comparison between acute gastrointestinal-graft-versus-host disease and infectious colitis in patients after hematopoietic stem cell transplantation.
Ohwada S; Iida T; Hirayama D; Sudo G; Kubo T; Nojima M; Yamashita K; Yamano H; Nakase H
PLoS One; 2018; 13(7):e0200627. PubMed ID: 30059537
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of endoscopic features of pediatric acute gastrointestinal graft-versus-host disease.
Hiejima E; Nakase H; Matsuura M; Honzawa Y; Higuchi H; Saida S; Umeda K; Hiramatsu H; Adachi S; Izawa K; Kawai T; Yasumi T; Nishikomori R; Heike T
Dig Endosc; 2016 Jul; 28(5):548-55. PubMed ID: 26773564
[TBL] [Abstract][Full Text] [Related]
9. Colonoscopy in the diagnosis of intestinal graft versus host disease and cytomegalovirus enteritis following allogeneic haematopoietic stem cell transplantation.
He JD; Liu YL; Wang ZF; Liu DH; Chen H; Chen YH
Chin Med J (Engl); 2008 Jul; 121(14):1285-9. PubMed ID: 18713549
[TBL] [Abstract][Full Text] [Related]
10. Site specific diagnostic yield of endoscopic biopsies in Gastrointestinal Graft-versus-Host Disease: A tertiary care Center experience.
Daniel F; Hassoun L; Husni M; Sharara A; Soweid A; Barada K; Haffar B; Massoud R; Shaib Y; Al-Hashash J; Bazarbachi A; El Cheikh J
Curr Res Transl Med; 2019 Feb; 67(1):16-19. PubMed ID: 30206046
[TBL] [Abstract][Full Text] [Related]
11. Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults.
Sung AD; Hassan S; Cardona DM; Wild D; Nichols KR; Mehdikhani H; Balmadrid B; Detweiler CJ; Shealy M; Cirrincione C; Li Z; Poleski M; Dalton TE; Siamakpour-Reihani S; Chao NJ; Sullivan KM
Biol Blood Marrow Transplant; 2018 Apr; 24(4):734-740. PubMed ID: 29246821
[TBL] [Abstract][Full Text] [Related]
12. Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy.
Cho BS; Yahng SA; Kim JH; Yoon JH; Shin SH; Lee SE; Choi SM; Lee DG; Eom KS; Park G; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Ann Hematol; 2013 Apr; 92(4):497-504. PubMed ID: 23180439
[TBL] [Abstract][Full Text] [Related]
13. Serial intestinal endoscopic examinations of patients with persistent diarrhea after allo-SCT.
Martínez C; Rosales M; Calvo X; Cuatrecasas M; Rodriguez-Carunchio L; Llach J; Fernández-Avilés F; Rosiñol L; Rovira M; Carreras E; Urbano-Ispízua A
Bone Marrow Transplant; 2012 May; 47(5):694-9. PubMed ID: 21743500
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Utility of Endoscopy and Biopsy in Suspected Acute Gastrointestinal Graft-versus-Host Disease after Hematopoietic Progenitor Cell Transplantation.
Scott AP; Tey SK; Butler J; Kennedy GA
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1294-1298. PubMed ID: 29410342
[TBL] [Abstract][Full Text] [Related]
15. Acute Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease Is Not Associated With Significant Differences in Gut Taxonomic Composition Compared to Steroid-Sensitive Gastrointestinal Graft-Versus-Host Disease Immediately Before Onset of Disease.
Zeng K; Brewster R; Kang JB; Tkachenko E; Brooks E; Bhatt AS; Fodor AA; Andermann TM
Transplant Cell Ther; 2024 Feb; 30(2):237.e1-237.e9. PubMed ID: 37944820
[TBL] [Abstract][Full Text] [Related]
16. Rectal biopsy, rather than ileal, is appropriate to confirm the diagnosis of early gastrointestinal graft-versus-host disease.
Minamino H; Machida H; Tominaga K; Morimoto K; Ominami M; Fukunaga S; Hosomi S; Hayashi Y; Nagami Y; Sugimori S; Kamata N; Shiba M; Nakamae H; Yamagami H; Tanigawa T; Watanabe T; Fujiwara Y; Ohsawa M; Hino M; Arakawa T
Scand J Gastroenterol; 2015; 50(11):1428-34. PubMed ID: 26061619
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic findings predict the histologic diagnosis in gastrointestinal graft-versus-host disease.
Cruz-Correa M; Poonawala A; Abraham SC; Wu TT; Zahurak M; Vogelsang G; Kalloo AN; Lee LA
Endoscopy; 2002 Oct; 34(10):808-13. PubMed ID: 12244503
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin and α1-antitrypsin dynamics in gastrointestinal GvHD.
O'Meara A; Kapel N; Xhaard A; Sicre de Fontbrune F; Manéné D; Dhedin N; de Latour RP; Socié G; Robin M
Bone Marrow Transplant; 2015 Aug; 50(8):1105-9. PubMed ID: 25961766
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial.
Zhao Y; Li X; Zhou Y; Gao J; Jiao Y; Zhu B; Wu D; Qi X
Front Immunol; 2021; 12():678476. PubMed ID: 34220825
[TBL] [Abstract][Full Text] [Related]
20. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
